• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Xenetic Biosciences, Inc. - Common Stock (NQ:XBIO)

2.910 +0.060 (+2.11%)
Streaming Delayed Price Updated: 12:02 PM EDT, Jun 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Xenetic Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Xenetic Biosciences, Inc. Announces That Its Collaboration Partner Received Approval From the Israeli Ministry of Health to Conduct Exploratory, Investigator Initiated Study of DNase I In Combination With Anti-CD19 CAR T Cells in Large B-Cell Lymphoma
June 04, 2026
Via ACCESS Newswire
News headline image
Xenetic Biosciences Showcases Compelling ASCO 2026 Data Demonstrating DNase I Significantly Enhances CAR-T Cell Persistence, Tumor Control, and Survival
June 01, 2026
Via ACCESS Newswire
News headline image
Xenetic Biosciences Reports First Quarter 2026 Financial Results and Highlights Continued Advancement of DNase Oncology Platform
May 13, 2026
Via ACCESS Newswire
News headline image
Xenetic Biosciences, Inc. Announces Abstract Acceptance for Presentation at the 2026 ASCO Annual Meeting
April 22, 2026
Via ACCESS Newswire
News headline image
Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results
March 13, 2026
Via ACCESS Newswire
News headline image
Why Did UPB Stock Pop 20% In Pre-Market Today? ↗
February 11, 2026
The company announced positive top-line results from its Phase 2 VALIANT trial evaluating Verekitug in adults with severe asthma. 
Via Stocktwits
News headline image
Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting
December 11, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
November 19, 2025
 
Via Benzinga
News headline image
Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform
November 19, 2025
Via ACCESS Newswire
News headline image
Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results
November 13, 2025
Via ACCESS Newswire
News headline image
Micron, Galecto And Xenetic Lead This Week's Benzinga Stock Ranking Surges ↗
October 10, 2025
Benzinga Edge Stock Rankings evaluate companies across four key factors. Here are three big companies that stood out this week. 
Via Benzinga
News headline image
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
October 10, 2025
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
October 10, 2025
 
Via Benzinga
News headline image
Which stocks are experiencing notable movement on Friday? ↗
October 10, 2025
Curious to know what's happening on the US markets in the middle of the day on Friday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
News headline image
Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock
October 10, 2025
Via ACCESS Newswire
News headline image
4 Stocks In The Same Sector Just Made A Huge Leap In Momentum Rankings ↗
October 09, 2025
Healthcare and biotech stocks have lagged broader markets this year, but a growing number of names have been picking up steam as the market rally broadens and major indexes continue to reach new highs.... 
Via Benzinga
News headline image
Which stocks are moving before the opening bell on Thursday? ↗
October 09, 2025
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
News headline image
Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket ↗
October 09, 2025
 
Via Benzinga
News headline image
MAGA Stocks Undercard: MYSE, XBIO, ATON, ACXP, RDZN – Innovators Driving Next Tech, Blockchain, AI Wave – More Stocks Inside
October 08, 2025
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
October 08, 2025
 
Via Benzinga
News headline image
Nasdaq Gains 150 Points; US Mortgage Applications Decline ↗
October 08, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
October 08, 2025
 
Via Benzinga
News headline image
Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket ↗
October 08, 2025
 
Via Benzinga
News headline image
Xenetic Biosciences, Inc. Reports Second Quarter 2025 Financial Results
August 13, 2025
Via ACCESS Newswire
News headline image
Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Large B Cell Lymphoma
July 30, 2025
Via ACCESS Newswire
News headline image
Xenetic Biosciences, Inc. Expands Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform
July 23, 2025
Via ACCESS Newswire
News headline image
Xenetic Biosciences, Inc. Announces Update from Collaboration Partner of First Patient Dosed in Exploratory Clinical Study of DNase I in Combination with FOLFIRINOX for the First Line Treatment of Unresectable, Locally Advanced or Metastatic Pancreatic
July 08, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
June 30, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
June 23, 2025
 
Via Benzinga
News headline image
Xenetic Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
May 14, 2025
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap